Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S L K Kristensen"'
Autor:
S A A Ali, M E Ersboll, N J V Vinding, J H B Butt, R R Rorth, C S Selmer, L M W Westergaard, U M M Mogensen, P E W Weeke, C J Jons, F G Gustafsson, E F Fosbol, L K Kober, S L K Kristensen
Publikováno v:
European Heart Journal. 43
Background Although thyroid dysfunction is a well-known complication of amiodarone treatment, population-based estimates of the short- and long-term incidence of this complication are lacking. In addition, it is not clear whether heart failure (HF) e
Autor:
Torp-Pedersen Ct, M S Schou, G G Gislason, Bochra Zareini, Lars Koeber, Paul Blanche, C S Selmer, Anders Holt, S L K Kristensen, M L Lamberts, Deepthi Rajan, M.M Malik
Publikováno v:
European Heart Journal. 41
Background Development of type 2 diabetes (T2D) is common in patients with heart failure (HF), but knowledge of future cardiovascular events is lacking. Purpose We compared risk of heart failure hospitalization (HFH) or death versus ischemic events i
Autor:
M L Lamberts, C T Pedersen, M E Malik, Lars Koeber, Paul Blanche, M S Schou, Bochra Zareini, C M R Rasmussen, J M McMurray, S L K Kristensen, N S Sattar, G G Gislason, Maria D'Souza, C A Andersson
Publikováno v:
European Heart Journal. 40
Background Reflecting recent clinical trial findings, updated type 2 diabetes (T2D) guidelines recommend targeting SGLT2 inhibitors at patients at risk of heart failure (HF)-related events and GLP-1 receptor agonists at those at greater risk of ather
Autor:
M S Schou, M L Lamberts, G G Gislason, Anders Holt, Christian Selmer, M J Jensen, R Roerth, S L K Kristensen, Bochra Zareini
Publikováno v:
European Heart Journal. 39